Unveiling the connection: long-chain non-coding RNAs and critical signaling pathways in breast cancer

R Thapa, O Afzal, G Kumar, AA Bhat… - … -Research and Practice, 2023 - Elsevier
Breast cancer is a complex and diverse condition that disrupts multiple signaling pathways
essential for cell proliferation, survival, and differentiation. Recently, the significant …

Sodium alginate-based drug delivery for diabetes management: A review

MAJ Shaikh, G Gupta, O Afzal, MM Gupta… - International journal of …, 2023 - Elsevier
Diabetes mellitus (DM) is among the biggest global health problems of the 21st century,
which is characterised by insufficient insulin secretion and results in the augmentation of …

PROTACs: Novel tools for improving immunotherapy in cancer

S Li, T Chen, J Liu, H Zhang, J Li, Z Wang, G Shang - Cancer Letters, 2023 - Elsevier
Posttranslational modifications (PTMs), such as phosphorylation, methylation, ubiquitination,
and acetylation, are important in governing protein expression levels. Proteolysis targeting …

Scutebarbatine A induces ROS-mediated DNA damage and apoptosis in breast cancer cells by modulating MAPK and EGFR/Akt signaling pathway

X Hao, P Feng, Y Zhang, F Wang, G Wang… - Chemico-Biological …, 2023 - Elsevier
Abstract Scutebarbatine A (SBT-A), a diterpenoid alkaloid, has exerted cytotoxicity on
hepatocellular carcinoma cells in our previous works. Here, the antitumor activity of SBT-A in …

Discovery of new thieno[2,3-d]pyrimidines as EGFR tyrosine kinase inhibitors for cancer treatment

EA Sobh, MA Dahab, EB Elkaeed… - Future Medicinal …, 2023 - Taylor & Francis
Background: EGFR has been considered a vital molecular target in cancer management.
Aim: The discovery of new thieno [2, 3-d] pyrimidine derivatives as EGFR tyrosine kinase …

[HTML][HTML] Enhanced in vitro and in vivo anticancer activity through the development of Sunitinib-Loaded nanoniosomes with controlled release and improved uptake

S Dehghan, A Naghipour, FZ Anbaji… - International Journal of …, 2023 - Elsevier
This study aims to develop sunitinib niosomal formulations and assess their in-vitro anti-
cancer efficiency against lung cancer cell line, A549. Sunitinib, a highly effective anticancer …

Harnessing chitosan-adorned liposomes for enhanced drug delivery in cancer

MAJ Shaikh, O Afzal, I Kazmi, SI Alzarea, M Jafar… - Journal of Drug Delivery …, 2023 - Elsevier
Cancer is a progressive disease that is caused by a combination of factors, including one's
genetics, environment, and lifestyle choices. The pillars of cancer management include …

Advances in erlotinib delivery systems: Addressing challenges and exploring opportunities in EGFR-targeted cancer therapies

M Pourmadadi, V Mohammadzadeh… - Inorganic Chemistry …, 2024 - Elsevier
Cancer development in various organs, including the breast, ovary, brain, bladder, colon,
and lung, is frequently connected to disturbances in the epidermal growth factor receptor …

Apoptosis-driven synergistic anti-cancer efficacy of ethyl acetate extract of Memecylon sisparense Gamble leaves and doxorubicin in in-vitro and in-vivo models of …

JL Uppu, VS Challa, NP Syamprasad… - … -Research and Practice, 2024 - Elsevier
In the spectrum of breast neoplasms, approximately 15 to 20% of all diagnosed cases are
triple-negative breast carcinoma. TNBC grows and spreads faster than other invasive breast …

[HTML][HTML] Transcriptome analysis reveals differences in cell cycle, growth and migration related genes that distinguish fibroblasts derived from pre-invasive and invasive …

WB Fang, M Medrano, P Cote, M Portsche… - Frontiers in …, 2023 - frontiersin.org
Background/Introduction As the most common form of pre-invasive breast cancer, ductal
carcinoma in situ (DCIS) affects over 50,000 women in the US annually. Despite …